China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 93   

Articles published

CBPO 94.84 -5.37 (-5.36%)
price chart
China Biologic Products, Inc. (NASDAQ:CBPO) Given $135-$146 PT Range
According to the analysts polled by Zack's Research, China Biologic Products, Inc. (NASDAQ:CBPO) has been given a one year consensus price target range of $135 to $146.
Company Shares of China Biologic Products, Inc. (NASDAQ:CBPO) Rally 3.03%  American Trade Journal
Brokerages Give Consensus Rating of "Strong Buy" to China Biologic ...  WKRB News
New Lifetime High Today: China Biologic Products (CBPO)
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Earnings of $0.86 per Share Expected for China Biologic Products, Inc ...  Markets Daily
China Biologic Products Downgraded by Zacks to Hold (CBPO)  Dakota Financial News
China Biologic Products (CBPO) Showing Signs Of Perilous Reversal Today
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Large Outflow of Money Witnessed in China Biologic Products, Inc.
China Biologic Products, Inc. (NASDAQ:CBPO) surged 1.41% during the last session. The last traded price was up 1.4 points at $100.11.
Shares of China Biologic Products, Inc. (NASDAQ:CBPO) Drops by -11.28%  OTC Outlook
China Biologic Products Inc (NASDAQ:CBPO) Publicized 2nd Quarter Results
[Capital Cube] China Biologic Products Inc (NASDAQ:CBPO) (TREND ANALYSIS) reports preliminary financial results for the quarter ended June 30, 2015.
Analysts Expect China Biologic Products to Announce $0.89 EPS (NASDAQ:CBPO)  Dakota Financial News
China Biologic Products, Inc. Price Target Update
China Biologic Products, Inc. (NASDAQ:CBPO): The mean short term price target for China Biologic Products, Inc. (NASDAQ:CBPO) has been established at $140.5 per share. The higher price target estimate is at $146 and the lower price target estimate is ...
Oversold Stocks To Watch: China Biologic Products Inc (NASDAQ:CBPO ...  Street Report
Brokerage Firm Focus: China Biologic Products, Inc. (NASDAQ:CBPO)  Markets Daily
Large Inflow of Money Witnessed in China Biologic Products, Inc.
The shares of China Biologic Products, Inc. (NASDAQ:CBPO) traded with a loss of -0.08 points or -0.07% in the most recent session.
China Biologic Products, Inc. Analyst Rating Update  OTC Outlook
China Biologic Products, Inc. (NASDAQ:CBPO) is Expected to Report $0.86 for Q1
According to analysts, China Biologic Products, Inc. (NASDAQ:CBPO) is expected to report earnings per share for the current fiscal quarter of $0.86.
Company Shares of China Biologic Products, Inc. Drops by -1.13%  American Trade Journal
Investor Insights on China Biologic Products Inc (NASDAQ:CBPO)
[PRNewswire] China Biologic Products Inc (NASDAQ:CBPO)(TREND ANALYSIS) a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2015 financial results on ...
Mid-Day Changers: China Biologic Products, Inc. (CBPO), Bellicum ...  WallStreet Scope
Bank of America Rating Update on China Biologic Products, Inc. (NASDAQ:CBPO)
Bank of America initiates coverage on China Biologic Products, Inc. (NASDAQ:CBPO). In the research report, Bank of America announces the target price to $135 per share on the shares.